TOP

Research Article

Split Viewer

Mol. Cells 2003; 16(3): 385-391

Published online January 1, 1970

© The Korean Society for Molecular and Cellular Biology

Enhanced Uptake of a Heterologous Protein with an HIV-1 Tat Protein Transduction Domains (PTD) at Both Termini

Jiyoon Ryu, Kyuhyung Han, Jinseu Park, Soo Young Choi

Abstract

Poor membrane permeability of proteins is a major limitation of protein therapy. In a previous study, we showed that the minimal sequence required for effi-cient transduction of Tat-GFP is the basic domain from 49-57 of HIV-1 Tat called the protein transduc-tion domain (PTD. Here we have generated HIV-1 Tat PTD GFP fusion proteins in which HIV-1 Tat PTD is fused with the N- and/or C-termini of GFP. The vari-ous GFP fusion proteins were purified from Es-cherichia coli and characterized for their ability to enter mammalian cells using Western blot analysis, confocal microscopy and flow cytometry. The GFP fusion protein with Tat PTD at its C-terminus was taken up as efficiently as the GFP fusion protein with Tat PTD at its N-terminus. However, the same protein with PTDs at its both termini was taken up even more efficiently. All the GFP fusion proteins were present in both the nucleus and cytosol of the transduced cells. Uptake was lower at 4

Keywords HIV-1-Tat; Protein Therapy; Protein Transduction; Tat-GFP-Tat; Transduction Efficiency

Article

Research Article

Mol. Cells 2003; 16(3): 385-391

Published online December 31, 2003

Copyright © The Korean Society for Molecular and Cellular Biology.

Enhanced Uptake of a Heterologous Protein with an HIV-1 Tat Protein Transduction Domains (PTD) at Both Termini

Jiyoon Ryu, Kyuhyung Han, Jinseu Park, Soo Young Choi

Abstract

Poor membrane permeability of proteins is a major limitation of protein therapy. In a previous study, we showed that the minimal sequence required for effi-cient transduction of Tat-GFP is the basic domain from 49-57 of HIV-1 Tat called the protein transduc-tion domain (PTD. Here we have generated HIV-1 Tat PTD GFP fusion proteins in which HIV-1 Tat PTD is fused with the N- and/or C-termini of GFP. The vari-ous GFP fusion proteins were purified from Es-cherichia coli and characterized for their ability to enter mammalian cells using Western blot analysis, confocal microscopy and flow cytometry. The GFP fusion protein with Tat PTD at its C-terminus was taken up as efficiently as the GFP fusion protein with Tat PTD at its N-terminus. However, the same protein with PTDs at its both termini was taken up even more efficiently. All the GFP fusion proteins were present in both the nucleus and cytosol of the transduced cells. Uptake was lower at 4

Keywords: HIV-1-Tat, Protein Therapy, Protein Transduction, Tat-GFP-Tat, Transduction Efficiency

Mol. Cells
Nov 30, 2023 Vol.46 No.11, pp. 655~725
COVER PICTURE
Kim et al. (pp. 710-724) demonstrated that a pathogen-derived Ralstonia pseudosolanacearum type III effector RipL delays flowering time and enhances susceptibility to bacterial infection in Arabidopsis thaliana. Shown is the RipL-expressing Arabidopsis plant, which displays general dampening of the transcriptional program during pathogen infection, grown in long-day conditions.

Share this article on

  • line

Molecules and Cells

eISSN 0219-1032
qr-code Download